FEBRUARY 2024LIFE SCIENCES REVIEW1LIFESCIENCESREVIEW.COMMAKING CELL THERAPY ACCESSIBLE TO ALL PATIENTSFEBRUARY - 19 - 2024ISSN 2831-8331CANADA SPECIALTHERAPEUTICSE DI T IO NNuala Trainor, Director of Innovation, Personalized Medicine, LonzaSteven Cohen, Executive Director, Translational Medicine-Oncology & Internal Medicine, & Business Development-IM,Daiichi Sankyo, Inc.
Page 2 >